These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3958372)

  • 1. Procainamide pharmacokinetics in patients with acute myocardial infarction or congestive heart failure.
    Kessler KM; Kayden DS; Estes DM; Koslovskis PL; Sequeira R; Trohman RG; Palomo AR; Myerburg RJ
    J Am Coll Cardiol; 1986 May; 7(5):1131-9. PubMed ID: 3958372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of disopyramide after intravenous infusion to patients with myocardial infarction and heart failure.
    Bonde J; Angelo HR; Bødtker S; Svendsen TL; Kampmann JP
    Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):278-82. PubMed ID: 4024955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procainamide accumulation kinetics in the immediate postmyocardial infarction period.
    Lalka D; Wyman MG; Goldreyer BN; Ludden TM; Cannom DS
    J Clin Pharmacol; 1978; 18(8-9):397-401. PubMed ID: 690250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of procainamide in patients with chronic congestive heart failure receiving medical therapy.
    Tisdale JE; Rudis MI; Padhi ID; Borzak S; Svensson CK; Webb CR; Acciaioli J; Ware JA; Krepostman A; Zarowitz BJ
    J Clin Pharmacol; 1996 Jan; 36(1):35-41. PubMed ID: 8932541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing procainamide total body clearance in the immediate postmyocardial infarction period.
    Wyman MG; Goldreyer BN; Cannon DS; Ludden TM; Lalka D
    J Clin Pharmacol; 1981 Jan; 21(1):20-5. PubMed ID: 7217340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia.
    Myerburg RJ; Kessler KM; Kiem I; Pefkaros KC; Conde CA; Cooper D; Castellanos A
    Circulation; 1981 Aug; 64(2):280-90. PubMed ID: 7249296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
    Woosley RL; Echt DS; Roden DM
    Am J Cardiol; 1986 Jan; 57(3):25B-33B. PubMed ID: 3080860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of procainamide from routine clinical data.
    Grasela TH; Sheiner LB
    Clin Pharmacokinet; 1984; 9(6):545-54. PubMed ID: 6509861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
    Bauer LA; Black D; Gensler A; Sprinkle J
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):213-6. PubMed ID: 2472362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capacity-limited elimination of procainamide in man.
    Tilstone WJ; Lawson DH
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):343-6. PubMed ID: 694230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.
    Somogyi A; Bochner F
    Br J Clin Pharmacol; 1984 Aug; 18(2):175-81. PubMed ID: 6091709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics in heart failure. An updated review.
    Shammas FV; Dickstein K
    Clin Pharmacokinet; 1988 Aug; 15(2):94-113. PubMed ID: 3064953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic comparison of two sustained-release oral procainamide preparations.
    Hore P; Bones P; Rollinson T; Ikram H
    Br J Clin Pharmacol; 1979 Sep; 8(3):267-71. PubMed ID: 497093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F
    Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model.
    O'Connor CM; Hathaway WR; Bates ER; Leimberger JD; Sigmon KN; Kereiakes DJ; George BS; Samaha JK; Abbottsmith CW; Candela RJ; Topol EJ; Califf RM
    Am Heart J; 1997 Jun; 133(6):663-73. PubMed ID: 9200394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
    J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide.
    Somberg JC; Tepper D; Sacher H; Schwarz J
    Am Heart J; 1987 Jul; 114(1 Pt 1):18-25. PubMed ID: 3111236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of procainamide.
    Karlsson E
    Clin Pharmacokinet; 1978; 3(2):97-107. PubMed ID: 346289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.